Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple Artemisinin-based Combination Therapy for Uncomplicated Plasmodium Falciparum Malaria
NCT05764746Phase 3Completed
- Sponsor
- Muhimbili University of Health and Allied Sciences
- Start
- May 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amodiaquine, artesunate + amodiaquine in Plasmodium falciparum malaria, sponsored by Muhimbili University of Health and Allied Sciences. Started May 2023; status: completed.
02
Drugs
amodiaquineartesunate + amodiaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT05764746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05764746.